RYTM
Rhythm Pharmaceuticals, Inc.
$109.69
-0.27 (-0.25%)
At close · Jul 15
Market Cap
$7.27B
Shares
68,532,607
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-25 | 2026-06-24 | |
| 8-K | 2026-06-15 | 2026-06-13 | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| DEF 14A | 2026-04-29 | 2026-06-24 | |
| 8-K | 2026-04-03 | 2026-04-01 | |
| 8-K | 2026-03-26 | — | |
| 8-K | 2026-03-20 | 2026-03-19 | |
| 8-K | 2026-03-16 | — | |
| 8-K | 2026-03-02 | — | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-01-09 | — | |
| 8-K | 2025-12-19 | 2025-12-16 | |
| 8-K | 2025-12-11 | — | |
| 8-K | 2025-11-07 | 2025-11-06 | |
| 8-K | 2025-11-04 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-07-11 | 2025-07-09 | |
| 8-K | 2025-07-09 | — | |
| 8-K | 2025-06-26 | 2025-06-24 | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| DEF 14A | 2025-04-29 | 2025-06-24 | |
| 8-K | 2025-04-07 | — | |
| 8-K | 2025-03-20 | 2025-03-14 | |
| 8-K | 2025-02-28 | 2025-02-27 | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-26 | — | |
| 8-K | 2025-01-10 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-11-05 | — | |
| 8-K | 2024-09-19 | 2024-09-18 | |
| 10-Q/A | 2024-08-14 | 2024-06-30 | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-07-10 | — | |
| 8-K | 2024-06-17 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| 8-K | 2024-05-07 | — | |
| DEF 14A | 2024-04-26 | 2024-06-18 | |
| 8-K | 2024-04-16 | 2024-04-15 | |
| 8-K | 2024-04-01 | — | |
| 8-K | 2024-02-29 | — | |
| 10-K | 2024-02-29 | 2023-12-31 | |
| 8-K | 2024-02-22 | — | |
| 8-K | 2024-01-04 | — | |
| 8-K | 2024-01-04 | — |
Showing 1–50 of 116 filings
Key facts
CIK
1649904
CUSIP
76243J105
13F (30d)
21 filings
20 filers
Visit website
Investor relations